CAMP FY 2022 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$45M

Net Income

-$44M

EPS (Diluted)

$-0.90

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$43M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$103M

Total Liabilities

$180M

Stockholders' Equity

-$78M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$296M	-100.0%
Gross Profit	$0	$122M	-100.0%
Operating Income	-$45M	-$15M	-193.9%
Net Income	-$44M	-$31M	-41.9%